[SLRX] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
01-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -11.00%
YoY- 72.88%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 1,039 875 165 105 163 251 246 160.60%
PBT -1,882 -2,630 -1,385 -2,230 -2,009 -2,638 -9,052 -64.80%
Tax 1 -2 0 0 -51 0 0 -
NP -1,883 -2,628 -1,385 -2,230 -2,009 -2,638 -9,052 -64.79%
Tax Rate - - - - - - - -
Total Cost 2,922 3,503 1,549 2,335 2,172 2,889 9,297 -53.67%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -181.27 -300.33 -840.76 -2,124.68 -1,232.52 -1,051.18 -3,687.09 -86.50%
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -14.40 -18.22 -11.48 -77.16 -69.50 -91.27 -313.66 -87.10%
EPS Diluted -14.40 -18.22 -11.48 -77.16 -69.50 -91.27 -313.66 -87.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.